Has Daniel Schwartz, MD received payments from drug or device companies?

Yes. Drug and device makers reported $423,854 in general payments to Daniel Schwartz, MD across 367 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Daniel Schwartz, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Daniel Schwartz, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Daniel Schwartz, MD

Orthopaedic Surgery · Seattle, WANPI 1003063165

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $369,812 of the $423,854 with a category attached, or 87.2%. 12 manufacturers reported payments, led by Medical Device Business Services, Inc. at 50.8% of the total. Reporting peaked in 2021 at $107,676 and has fallen 54.0% since, to $49,484 in 2025. Among orthopaedic surgery clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$423,854in general payments, 2019–2025

Across 367 payments — averaging $1154.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medical Device Business Services, Inc.$215K
Encore Medical, LP$191K
Depuy Synthes Products, Inc.$13K
Johnson & Johnson$3K
Stryker$468
Insight Medical Systems, Inc.$213
plus $477 from 6 others

$83,727in ownership & investment interests, 2019–2025

Across 1 payment — averaging $83,727 each. An ownership or investment interest held by the physician or an immediate family member.

Zurimed Technologies Inc.$84K

What the payments were for

Consulting fees$369,81287%
Speaking & faculty fees$12,8883%
Travel & lodging$33,4578%
Food & beverage$7,6972%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medical Device Business Services, Inc.	83	$215,475
Encore Medical, LP	122	$190,787
Depuy Synthes Products, Inc.	9	$13,305
Johnson & Johnson	142	$3,130
Stryker	2	$468
Insight Medical Systems, Inc.	1	$213
Zimmer Biomet	2	$135
Treace Medical Concepts, Inc.	1	$130
Next Science LLC	1	$120
Invictus Surgical Incorporated	1	$39
Amgen(2 entities)	2	$38
Ossio Inc	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DJO SURGICAL$253,154
MILAGRO$162,138
DJO Surgical AltiVate Reverse$46,820
DJO Surgical AltiVate Anatomic System$45,852
HEALIX$8,336
INHANCE$1,291
ENDURANCE$397
DJO Surgical Discovery Elbow System$300
DJO Surgical Match Point System$300
BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$266
ARVIS$213
AEQUALIS ASCEND FLEX$202
TORNIER PERFORM REVERSED AUGMENTED GLENOID$202
AEQUALIS FLEX REVIVE$202
BRISTOW-LATARJET$148
Gryphon Orthocord$148
Lapiplasty System$130
SurgX$120
Xperience$120
FMS Duo$101

How this compares

$423,854 in reported general payments places this provider in the 95th percentile of 495 orthopaedic surgery providers in Washington.

See all orthopaedic surgery providers in Washington →

Medicare billing

Part B allowed, 2024

$165,246

Medicare patients

188

Services billed

736

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	76	$942
Ondansetron OdtOndansetron	34	$432
Cephalexin	37	$249
Oxycodone Hcl	17	$122
Diclofenac Sodium	32	$122

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Seattle

James PritchettSeattle$6.4M
James CrutcherSeattle$3.5M
Keith MayoSeattle$3.1M
Matthew SaltzmanSeattle$1.8M
Burt YaszaySeattle$1.3M
Sean ToomeySeattle$1.2M
Robert HartSeattle$942K
Jeffrey RohSeattle$604K
Michael BrageSeattle$496K
Grant GarciaSeattle$367K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →